|
|
|
|
|
| October 27, 2011 | ISSUE NUMBER 223 VOL 8 |
|
Special Feature
30 Years, 30 Pharma Leaders
As Pharm Exec magazine reaches its 30th birthday, we profile 30 people who have been among the most influential in shaping biopharma in the last three decades ...Read More
Forecast
Pharma Futures: The Next 30 Years
Over the next five years, nearly two-thirds of pharmaceutical sales growth is forecast to come from emerging markets. This represents about $150 billion in new revenues and will raise the share of pharmaceutical sales from emerging markets to close to 30 percent of the global total ...Read More
Economy
Will Biological Research Boost US Jobs?
When he signed the America Invents Act in September, President Obama committed to developing a National Bioeconomy Blueprint by January 2012. The blueprint will describe ways to manage investment in biological research to improve the nation’s health and create the “jobs of the future”
...Read More
C-Suite
Inside the Mind of the CEO
Pharm Exec sits down with Steve Collis, CEO of AmerisourceBergen, to discuss his agenda for retooling the drug distribution giant ...Read more
|
|
|
 // Aegerion Pharmaceuticals (Cambridge, Mass.) announced the appointment of Craig E. Fraser as President, US.
// David Kramer, CEO of Digitas Health and Razorfish Health (Philadelphia), announced that he will be leaving his position at the end of 2011. Alexandra von Plato and Michael du Toit, who were appointed co-presidents of Digitas Health and Razorfish Health this past July, will assume leadership of the companies after Kramer’s departure. // Debbie Malovetz joined MTI (Langhorne, Pa.) as Vice President, Strategic Services. //
The following professionals have been appointed to the Board of Directors of ISPE (Tampa): Arthur “Randy” Perez, PhD (Chairman), Director, IT Risk Management and Compliance for Novartis; Charlotte Enghave Fruergaard, PhD (Vice Chairman), Director of Technology, Process, and Compliance, at NNE Pharmaplan (Denmark); Damian Greene (Treasurer), Senior Director, Network Strategy, for Pfizer Global Supply; and Brian H. Lange, PE (Secretary), PMO Operations Director, Merck.
|
|
|
|
|
|
|
|
 |
|
 |
| |
 |
| |
 |
 |
|
 |
Do you think FDA and USP should work more closely together on monographs and general chapters?
a) Yes
b) No
|
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
